612 related articles for article (PubMed ID: 31445042)
1. Sarm1 deletion reduces axon damage, demyelination, and white matter atrophy after experimental traumatic brain injury.
Marion CM; McDaniel DP; Armstrong RC
Exp Neurol; 2019 Nov; 321():113040. PubMed ID: 31445042
[TBL] [Abstract][Full Text] [Related]
2. Genetic inactivation of SARM1 axon degeneration pathway improves outcome trajectory after experimental traumatic brain injury based on pathological, radiological, and functional measures.
Bradshaw DV; Knutsen AK; Korotcov A; Sullivan GM; Radomski KL; Dardzinski BJ; Zi X; McDaniel DP; Armstrong RC
Acta Neuropathol Commun; 2021 May; 9(1):89. PubMed ID: 34001261
[TBL] [Abstract][Full Text] [Related]
3. Experimental Traumatic Brain Injury Identifies Distinct Early and Late Phase Axonal Conduction Deficits of White Matter Pathophysiology, and Reveals Intervening Recovery.
Marion CM; Radomski KL; Cramer NP; Galdzicki Z; Armstrong RC
J Neurosci; 2018 Oct; 38(41):8723-8736. PubMed ID: 30143572
[TBL] [Abstract][Full Text] [Related]
4. White matter involvement after TBI: Clues to axon and myelin repair capacity.
Armstrong RC; Mierzwa AJ; Marion CM; Sullivan GM
Exp Neurol; 2016 Jan; 275 Pt 3():328-333. PubMed ID: 25697845
[TBL] [Abstract][Full Text] [Related]
5. Traumatic axonopathy in spinal tracts after impact acceleration head injury: Ultrastructural observations and evidence of SARM1-dependent axonal degeneration.
Alexandris AS; Lee Y; Lehar M; Alam Z; Samineni P; Tripathi SJ; Ryu J; Koliatsos VE
Exp Neurol; 2023 Jan; 359():114252. PubMed ID: 36244414
[TBL] [Abstract][Full Text] [Related]
6. Sarm1 loss reduces axonal damage and improves cognitive outcome after repetitive mild closed head injury.
Maynard ME; Redell JB; Zhao J; Hood KN; Vita SM; Kobori N; Dash PK
Exp Neurol; 2020 May; 327():113207. PubMed ID: 31962129
[TBL] [Abstract][Full Text] [Related]
7. Neuronal tau pathology worsens late-phase white matter degeneration after traumatic brain injury in transgenic mice.
Yu F; Iacono D; Perl DP; Lai C; Gill J; Le TQ; Lee P; Sukumar G; Armstrong RC
Acta Neuropathol; 2023 Oct; 146(4):585-610. PubMed ID: 37578550
[TBL] [Abstract][Full Text] [Related]
8. Myelin and oligodendrocyte lineage cells in white matter pathology and plasticity after traumatic brain injury.
Armstrong RC; Mierzwa AJ; Sullivan GM; Sanchez MA
Neuropharmacology; 2016 Nov; 110(Pt B):654-659. PubMed ID: 25963414
[TBL] [Abstract][Full Text] [Related]
9. Attenuated traumatic axonal injury and improved functional outcome after traumatic brain injury in mice lacking Sarm1.
Henninger N; Bouley J; Sikoglu EM; An J; Moore CM; King JA; Bowser R; Freeman MR; Brown RH
Brain; 2016 Apr; 139(Pt 4):1094-105. PubMed ID: 26912636
[TBL] [Abstract][Full Text] [Related]
10. Traumatic Axonal Injury in the Optic Nerve: The Selective Role of SARM1 in the Evolution of Distal Axonopathy.
Alexandris AS; Lee Y; Lehar M; Alam Z; McKenney J; Perdomo D; Ryu J; Welsbie D; Zack DJ; Koliatsos VE
J Neurotrauma; 2023 Aug; 40(15-16):1743-1761. PubMed ID: 36680758
[TBL] [Abstract][Full Text] [Related]
11. Components of myelin damage and repair in the progression of white matter pathology after mild traumatic brain injury.
Mierzwa AJ; Marion CM; Sullivan GM; McDaniel DP; Armstrong RC
J Neuropathol Exp Neurol; 2015 Mar; 74(3):218-32. PubMed ID: 25668562
[TBL] [Abstract][Full Text] [Related]
12. Primary Traumatic Axonopathy in Mice Subjected to Impact Acceleration: A Reappraisal of Pathology and Mechanisms with High-Resolution Anatomical Methods.
Ziogas NK; Koliatsos VE
J Neurosci; 2018 Apr; 38(16):4031-4047. PubMed ID: 29567804
[TBL] [Abstract][Full Text] [Related]
13. Acute axon damage and demyelination are mitigated by 4-aminopyridine (4-AP) therapy after experimental traumatic brain injury.
Radomski KL; Zi X; Lischka FW; Noble MD; Galdzicki Z; Armstrong RC
Acta Neuropathol Commun; 2022 May; 10(1):67. PubMed ID: 35501931
[TBL] [Abstract][Full Text] [Related]
14. Prevention of vincristine-induced peripheral neuropathy by genetic deletion of SARM1 in mice.
Geisler S; Doan RA; Strickland A; Huang X; Milbrandt J; DiAntonio A
Brain; 2016 Dec; 139(Pt 12):3092-3108. PubMed ID: 27797810
[TBL] [Abstract][Full Text] [Related]
15. Role of SARM1 and DR6 in retinal ganglion cell axonal and somal degeneration following axonal injury.
Fernandes KA; Mitchell KL; Patel A; Marola OJ; Shrager P; Zack DJ; Libby RT; Welsbie DS
Exp Eye Res; 2018 Jun; 171():54-61. PubMed ID: 29526794
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological SARM1 inhibition protects axon structure and function in paclitaxel-induced peripheral neuropathy.
Bosanac T; Hughes RO; Engber T; Devraj R; Brearley A; Danker K; Young K; Kopatz J; Hermann M; Berthemy A; Boyce S; Bentley J; Krauss R
Brain; 2021 Nov; 144(10):3226-3238. PubMed ID: 33964142
[TBL] [Abstract][Full Text] [Related]
17. Rostrocaudal analysis of corpus callosum demyelination and axon damage across disease stages refines diffusion tensor imaging correlations with pathological features.
Xie M; Tobin JE; Budde MD; Chen CI; Trinkaus K; Cross AH; McDaniel DP; Song SK; Armstrong RC
J Neuropathol Exp Neurol; 2010 Jul; 69(7):704-16. PubMed ID: 20535036
[TBL] [Abstract][Full Text] [Related]
18. Genetic diversity of axon degenerative mechanisms in models of Parkinson's disease.
Peters OM; Weiss A; Metterville J; Song L; Logan R; Smith GA; Schwarzschild MA; Mueller C; Brown RH; Freeman M
Neurobiol Dis; 2021 Jul; 155():105368. PubMed ID: 33892050
[TBL] [Abstract][Full Text] [Related]
19. Genetic ablation of Sarm1 attenuates expression and mislocalization of phosphorylated TDP-43 after mouse repetitive traumatic brain injury.
Dogan EO; Bouley J; Zhong J; Harkins AL; Keeler AM; Bosco DA; Brown RH; Henninger N
Acta Neuropathol Commun; 2023 Dec; 11(1):206. PubMed ID: 38124145
[TBL] [Abstract][Full Text] [Related]
20. Sarm1 Deletion, but Not Wld
Gilley J; Ribchester RR; Coleman MP
Cell Rep; 2017 Oct; 21(1):10-16. PubMed ID: 28978465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
